Hudson Bay Capital Management
XLRN

Hudson Bay Capital Management’s Acceleron Pharma XLRN Stock Holding History

Hudson Bay Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-65,000
Closed -$3.45M – 611
2019
Q4 		$3.45M Buy
65,000
+35,000
+117% +$1.6M 0.08% 225
2019
Q3 		$1.19M Buy
+30,000
New +$1.3M 0.03% 302

Hudson Bay Capital Management's XLRN Position: Q4 2021 in Review

Hudson Bay Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 20,000 shares — an estimated $3.44M sold.

Hudson Bay Capital Management first reported a position in XLRN in Q1 2017 and held it in 14 quarters. The position peaked at $8.62M in Q1 2019. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Hudson Bay Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Hudson Bay Capital Management sold 20,000 Acceleron Pharma shares in Q4 2021, an estimated $3.44M.
  • Hudson Bay Capital Management first reported a position in Acceleron Pharma in Q1 2017 and held it in 14 quarters.
  • Hudson Bay Capital Management's Acceleron Pharma position peaked at $8.62M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Hudson Bay Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.